secwatch / observer
8-K filed August 30, 2024, 7:59 PM ET ticker BDX CIK 0000010795
leadership confidence high sentiment neutral materiality 0.50

BDX reassigns Thomas Spoerel to SVP, CFO Regions; DelOrefice interim principal accounting officer

BECTON DICKINSON & CO

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Christopher DelOrefice

interim principal accounting officer
BDX · BECTON DICKINSON & CO
Effective
2024-08-30
Filed
August 30, 2024, 7:59 PM ET
Christopher DelOrefice, Executive Vice President and Chief Financial Officer, will assume the responsibilities of principal accounting officer on an interim basis.
Role change

Thomas Spoerel

Senior Vice President, CFO Regions
BDX · BECTON DICKINSON & CO
Effective
2024-08-30
Successor
Christopher DelOrefice
Filed
August 30, 2024, 7:59 PM ET
Thomas Spoerel will serve as the Senior Vice President, CFO Regions along with finance leadership for the finance integration of the recently announced agreement for Becton Dickinson to acquire the Edwards Life Sciences’ Critical Care product group.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Christopher DelOrefice was appointed as interim principal accounting officer at BECTON DICKINSON & CO.

Action
appointed
Role
interim principal accounting officer
Exact text from the filing
Christopher DelOrefice, Executive Vice President and Chief Financial Officer, will assume the responsibilities of principal accounting officer on an interim basis.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Thomas Spoerel was appointed as Senior Vice President, CFO Regions at BECTON DICKINSON & CO.

Action
appointed
Role
Senior Vice President, CFO Regions
Exact text from the filing
Thomas Spoerel will serve as the Senior Vice President, CFO Regions along with finance leadership for the finance integration of the recently announced agreement for Becton Dickinson to acquire the Edwards Life Sciences’ Critical Care product group.
View on SEC.gov

BECTON DICKINSON & CO filing history →

Source: SEC EDGAR
accession 0000950103-24-012970
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.